# RiSolubles™, the Soluble Fraction of Rice Bran for HIV-Infected Patients

> **NCT00480350** · PHASE2 · UNKNOWN · sponsor: **Hadassah Medical Organization** · enrollment: 140 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **BEHAVIORAL:** rice based food supplement

## Key facts

- **NCT ID:** NCT00480350
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-09
- **Primary completion:** —
- **Final completion:** 2009-01
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2007-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00480350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00480350, "RiSolubles™, the Soluble Fraction of Rice Bran for HIV-Infected Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00480350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*